Hospital Universitario de la Princesa -ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2020

  1. Results of an early access treatment protocol of daratumumab monotherapy in spanish patients with relapsed or refractory multiple myeloma

    HemaSphere, Vol. 4, Núm. 3

2015

  1. Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months

    Cancer Medicine, Vol. 4, Núm. 7, pp. 995-1002

2014

  1. Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor?

    American Journal of Hematology, Vol. 89, Núm. 11, pp. E206-E211

2007

  1. Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients

    Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 12, pp. 1448-1454

2003

  1. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: No differences in cytogenetic responses

    Annals of Hematology, Vol. 82, Núm. 12, pp. 750-758

  2. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051

1998

  1. Tratamiento con interferon alfa linfoblastoide en pacientes con leucemia mieloide crónica resistente a interferon alfa 2 recombinante

    Sangre, Vol. 43, Núm. 5, pp. 443-447

1997

  1. Magnetic resonance imaging features of chloroma of the shoulder

    Skeletal Radiology, Vol. 26, Núm. 1, pp. 70-72

1996

  1. Imipenem combinado con teicoplanina o vancomicina en el tratamiento empírico inicial de la neutropenia febril. Análisis de la respuesta primaria y de una estrategia secuencial global en 126 episodios

    Revista Clinica Espanola, Vol. 196, Núm. 8, pp. 515-522

  2. Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha)

    American Journal of Hematology, Vol. 53, Núm. 3, pp. 169-174

1995

  1. Hypertriglyceridemia may be severe in CML patients treated with interferon‐α

    American Journal of Hematology, Vol. 49, Núm. 3, pp. 240-241

  2. Subacute thyroiditis associated with interferon-α2a therapy [1]

    Hormone and Metabolic Research

  3. TRASPLANTE ALOGENICO DE MEDULO OSEA EN LA LEUCEMIA MIELOIDE CRONICA. RESULTADOS CLINICOS Y FACTORES DE RIESGO EN 70 PACIENTES

    Medicina Clinica, Vol. 105, Núm. 16, pp. 605-611

1994

  1. INFECCIONES BACTERIANAS PRECOCES EN 103 PACIENTES TRATADOS CON TRASPLANTE DE MEDULA OSEA

    Sangre, Vol. 39, Núm. 3, pp. 191-196